Patrick Roche Email & Phone Number

Tucson, Arizona Area

Dr. Roche is responsible for all IVD and RUO reagent and assay development, and actively interfaces with pharmaceutical and academic partners in their development of new therapeutics,

Tucson, Arizona Area

As Head of Scientific Affairs and Biomarker Strategy, Dr. Roche interfaces with pharmaceutical partners in their development of targeted cancer therapeutics, facilitating the transition of biomarkers into companion diagnostics.

Tucson, Arizona Area

Pat joined Ventana in August 2002 to lead the Reagent Product Development Team, launching more than thirty In Vitro Diagnostic products, comprising a portfolio of rabbit monoclonal antibodies, an immunohistochemistry panel to evaluate breast cancer, and a series of detection chemistries including enzyme metallography. During his tenure as head of Reagent Development, Dr. Roche established a GMP core facility for production of monoclonal antibodies, cell line controls, and enzyme-antibody conjugates. He also supervised the formation and recruitment for Ventana’s Clinical Affairs and Biostatistics Division. Recently Pat was an industry representative to the ASCO-CAP Committees on HER2 and ER/PR Testing. Dr. Roche has co-authored more than 115 peer-reviewed publications.

Rochester, Minnesota Area

Dr. Roche spent twenty years in Rochester, Minnesota serving as Director of the Immunohistochemistry Clinical Laboratory and Associate Professor of Pathology and Biochemistry-Molecular Biology for the Mayo Clinic. He also maintained NIH/NCI supported research in reproductive endocrinology and early detection/diagnosis of breast cancer, served as the director of the Tissue Acquisition Core for the Mayo Cancer Center and was chair of Translational Research for the North Central Cancer Treatment Group (NCCTG). He was a member of the CAP Immunohistochemistry Committee for ten years. Dr. Roche has co-authored more than 115 peer-reviewed publications.

Phd, Experimental Pathology

Bachelor Of Science, Biological Sciences